(Total Views: 489)
Posted On: 03/06/2020 7:57:05 AM
Post# of 154078
We already know documented treatment for one patient who died was given lopinavir plus ritonavir
He was given interferon alfa-2b (5 million units twice daily, atomisation inhalation) and lopinavir plus ritonavir (500 mg twice daily, orally) as antiviral therapy, and moxifloxacin (0·4 g once daily, intravenously) to prevent secondary infection.
Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections. ... It is the only PI coformulated with ritonavir, whose pharmacological boosting effect results in a highly potent, well-tolerated, clinically effective antiretroviral agent with a high genetic barrier to resistance.
.
He was given interferon alfa-2b (5 million units twice daily, atomisation inhalation) and lopinavir plus ritonavir (500 mg twice daily, orally) as antiviral therapy, and moxifloxacin (0·4 g once daily, intravenously) to prevent secondary infection.
Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections. ... It is the only PI coformulated with ritonavir, whose pharmacological boosting effect results in a highly potent, well-tolerated, clinically effective antiretroviral agent with a high genetic barrier to resistance.
.
(0)
(0)
